About the Role
Drives the clinical development of assigned asset(s), contributes as Development Team Japan (DT-J) Lead, and represents DT-J to internal/external stakeholders.
Responsibilities
- Leadership of Japan clinical development programs.
- Development and execution of Clinical Development Plan (CDP) in collaboration with Global Asset Team or relevant Global functions.
- Accountabilities as a country level for strategic design and delivery of CDP for assigned asset(s) in line with the target product profiles (TPP) and access considerations.
- Optimization of studies / programs for complexity, schedule, cost, quality.
- Identification of risks and assurance of mitigation plans.
- Incorporation of clinical / medical science insights into the clinical development strategy, plans and study designs.
- Responsible for Japan inputs in the creation of clinical components of key documents (e.g., trial protocols, Investigator’s Brochures, CSRs, regulatory documents) and execution.
- Contribution to successful regulatory filings, approvals, and launches in Japan.
- Support market access, commercialization, and maintenance of product licenses for assigned asset(s).
- Accountable for the comprehensive Japan clinical development programs and studies for assigned asset(s) and applicable indications.
- Accountable and responsible to develop and manage a network of Japan external experts to collect disease and patient unmet need insights that inform clinical development strategy.
- Responsible for providing Japan inputs, defending and updating clinical development plan (CDP) / clinical study design for each indication for the assigned asset, in line with TPP and Japan regulatory (post-approval) requirements in collaboration with Global Asset Team or relevant Global functions.
- Responsible for integrating up-to-date scientific/medical, statistical, Japanese regulatory/HTA, patient and clinical operations insights into a fit-for-purpose CDP/study concept/study protocol considering reduction of overall protocol complexity.
- Accountable for overseeing the ongoing evaluation of study efficacy/safety and data quality, effectively and efficiently interact with partners, key opinion leaders and investigators.
- Accountable for the ongoing evaluation of the benefit/risk ratio of the compound at asset and indication level.
- Accountable for result interpretation (RIM) and reporting (CSR).
- Responsible to lead Japan Development Team (DT-J) assigned asset(s) in a matrix organization.
- Responsible to lead the clinical team in the planning and timely execution of high quality clinical components of regulatory submissions for the indication(s)/formulation(s); contributes to the development and finalization of Japan clinical submission documents.
- Responsible to present and justify Japan clinical development strategic position and plan to internal (Governance bodies at program and study level) and external stakeholders (Regulatory Authorities, strategic partners).
- Responsible for providing drug development and therapeutic expertise to Business Development by contributing to the evaluation of licensing-in compounds.
- Responsible to present at conferences, symposia, and meetings with Japan Investigators and Key Opinion Leaders within the scope of the role.
- Accountable for audit/inspection readiness and overall compliance with regulations (eg, ICH GCP) in Japan and applicable quality standards at all times.
Requirements
- Over 5 years of experience in biopharmaceutical-clinical development is required.
- Experience of strategic design of global clinical programs.
- Experience of oversight of the planning and simultaneous delivery of multiple clinical studies.
- Experience of attendance at meetings with regulatory authorities and applicable external stakeholders.
- Experience of clinical contribution to regulatory submissions and life cycle management.
- Preferably has previously led a part or an entire clinical program.
Skills
- Leadership
- Clinical development strategy
- Clinical Development Plan (CDP) development and execution
- Risk identification and mitigation
- Scientific/medical insights integration
- Regulatory document creation
- Regulatory filings, approvals, and launches
- Market access support
- Commercialization support
- Product license maintenance
- Collaboration with internal stakeholders (Medical Affairs, Commercial, Pharmacovigilance)
- Global Asset Team engagement
- External stakeholder network management (regulatory authorities, key opinion leaders, patient advocacy groups)
- Compliance with regulations, SOPs, and quality standards
- Knowledge sharing
- Clinical study design
- Benefit/risk ratio evaluation
- Result interpretation and reporting
- Matrix organization leadership
- Clinical team leadership
- Regulatory submission document development
- Presentation and justification of clinical development strategy
- Drug development expertise
- Therapeutic expertise
- Business Development evaluation
- Conference presentation
- Audit/inspection readiness
Location
- Japan
Work Type
- Full-time
Experience Level
- Over 5 years of experience
- Preferably has previously led a part or an entire clinical program
Education Level
- Medical Degree (M.D.) - Preferred
About the Company
- UCB is a global biopharmaceutical company focusing on the fields of neurology and immunology.
- Around 8,500 employees worldwide are inspired by patients and driven by science.
- At UCB, we value creating value, not just doing work.
- We strive to achieve results for patients by embracing challenges, collaborating, and pursuing innovation.
- A culture of compassion and support is embedded, where everyone is respected, accepted, and can do their best.
- We always aim for 'what's next', delivering human-centered value for patients, employees, and the planet.
- Working at UCB allows you to experience personal growth, build your career freely, and reach your full potential.
Equal Opportunity
- UCB values equal opportunity.
- All hiring decisions are made regardless of any legally protected attribute.
- If you require special consideration during the selection process to fully demonstrate your strengths and abilities, please contact EMEA-Reasonable_Accommodation@ucb.com.
- Please note that this contact point is only for consultations regarding special considerations in the selection process.
